Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data Sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Cloning and mutagenesis industry 3600 synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Product trends
2.1.4 Technology trends
2.1.5 End-use trends
Chapter 3 Cloning and Mutagenesis Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing demand for precision medicine
3.2.1.2 Rising demand for genetically modified products
3.2.1.3 Advancements in genetic engineering techniques
3.2.2 Industry pitfalls & challenges
3.2.2.1 High maintanance cost of cloning and mutagenesis tools & instruments
3.2.2.2 Limited availability of qualified researchers
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By technology
3.3.3 By end-use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Technology lndscape
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard, 2022
Chapter 5 Cloning and Mutagenesis Market Size and Forecast, By Product (USD Million)
5.1 Key trends, by product
5.2 Cloning kits
5.3 Mutagenesis kits
5.4 Other products
Chapter 6 Cloning and Mutagenesis Market Size and Forecast, By Technology (USD Million)
6.1 Key trends, by technology
6.2 TOPO PCR cloning
6.3 Blunt end cloning
6.4 Seamless cloning
6.5 Site-directed mutagenesis
6.6 Other technologies
Chapter 7 Cloning and Mutagenesis Market Size and Forecast, By End-use (USD Million)
7.1 Key trends, by end-use
7.2 Biotechnology & pharmaceutical companies
7.3 CROs & CDMOs
7.4 Academic & research institutes
Chapter 8 Cloning and Mutagenesis Market Size and Forecast, By Region (USD Million)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 MEA
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 Rest of MEA
Chapter 9 Company Profiles
9.1 Agilent Technologies, Inc.
9.2 Thermo Fisher Scientific, Inc.
9.3 Takara Bio Inc.
9.4 Merck KGaA
9.5 Bio-Rad Laboratories, Inc.
9.6 Danaher
9.7 Jena Bioscience GmbH
9.8 New England Biolabs
9.9 Promega Corporation
9.10 Assay Genie
9.11 TransGen Biotech Co., Ltd.
9.12 GenScript
9.13 Genomax Technologies Pte Ltd
9.14 Genes2Me
